Despite the adoption of the World Trade Organization (WTO) Doha Declaration on the Agreement on Trade Related aspects of Intellectual Property Rights (TRIPS) and Public Health in 2001, which unequivocally affirmed WTO members’ rights to use compulsory licences and other TRIPS flexibilities to access essential medicines, thirteen years on, developing countries and least developed countries are still grappling with access to medicines issues and a high disease burden. Despite some well-researched and eloquent arguments to the contrary, it is a trite fact that patents remain an impediment to access to medicines by encouraging monopolistic prices. In the Southern African Development Community (SADC), a number of possible solutions to the access...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
476 p.Incentive to research and development (R&D), innovation and price are central in the issue of ...
The connection between patents for pharmaceuticals and access to affordable medicines has elicited c...
The connection between patents for pharmaceuticals and access to affordable medicines has elicited c...
Abstract High medicines prices increasingly pose challenges for universal access to treatments of co...
A major target of Goal 3 of the Sustainable Development Goals adopted by the United Nations in 2015 ...
In the pharmaceutical context, many Southern African Development Community (SADC) members grant pate...
In the pharmaceutical context, many Southern African Development Community (SADC) members grant pate...
The World Trade Organisation (WTO) agreement on Trade-Related Aspects of Intellectual Property Right...
This paper examines the effects of the Trade-Related Aspects of Intellectual Property Rights (TRIPs)...
In the pharmaceutical context, many Southern African Development Community (SADC) members grant pate...
Despite the adoption of the Doha Declaration on the TRIPS Agreement and Public Health in 2001, which...
This paper discusses the ways in which countries of the Southern African Development Community (SAD...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
476 p.Incentive to research and development (R&D), innovation and price are central in the issue of ...
The connection between patents for pharmaceuticals and access to affordable medicines has elicited c...
The connection between patents for pharmaceuticals and access to affordable medicines has elicited c...
Abstract High medicines prices increasingly pose challenges for universal access to treatments of co...
A major target of Goal 3 of the Sustainable Development Goals adopted by the United Nations in 2015 ...
In the pharmaceutical context, many Southern African Development Community (SADC) members grant pate...
In the pharmaceutical context, many Southern African Development Community (SADC) members grant pate...
The World Trade Organisation (WTO) agreement on Trade-Related Aspects of Intellectual Property Right...
This paper examines the effects of the Trade-Related Aspects of Intellectual Property Rights (TRIPs)...
In the pharmaceutical context, many Southern African Development Community (SADC) members grant pate...
Despite the adoption of the Doha Declaration on the TRIPS Agreement and Public Health in 2001, which...
This paper discusses the ways in which countries of the Southern African Development Community (SAD...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
476 p.Incentive to research and development (R&D), innovation and price are central in the issue of ...